Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 26.58% vs 10.71% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 17.44% vs 5.47% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 152.27% vs 168.02% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 16.73% vs 19.10% in Mar 2024
Compare Profit and Loss Results of Shelter Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
50.00
61.00
-11.00
-18.03%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
50.00
61.00
-11.00
-18.03%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
37.00
38.00
-1.00
-2.63%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1.00
8.00
-7.00
-87.50%
Operating Expenses
0.00
1.00
-1.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
1.00
-1.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
40.00
51.00
-11.00
-21.57%
Operating Profit (PBDIT) excl Other Income
10.00
10.00
0.00
0.00%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
10.00
11.00
-1.00
-9.09%
Interest
0.00
2.00
-2.00
-100.00%
Profit before Depriciation and Tax
9.00
9.00
0.00
0.00%
Depreciation
0.00
3.00
-3.00
-100.00%
Profit Before Taxation & Exceptional Items
9.00
6.00
3.00
50.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
9.00
6.00
3.00
50.00%
Provision for Tax
2.00
1.00
1.00
100.00%
Profit After Tax
7.00
4.00
3.00
75.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
11.00
9.00
2.00
22.22%
Profit Available for appropriations
18.00
14.00
4.00
28.57%
Appropriations
18.00
14.00
4.00
28.57%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
6.26
3.31
2.95
89.12%
Profit And Loss - Net Sales
Net Sales 50.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 26.58% vs 10.71% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.07 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.44% vs 5.47% in Mar 2024
Profit And Loss - Interest
Interest 0.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 152.27% vs 168.02% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 7.24 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.73% vs 19.10% in Mar 2024






